发明授权
US07671023B2 Amylin agonist for treating depression, anxiety disorder and schizophrenia
失效
用于治疗抑郁症，焦虑障碍和精神分裂症的胰岛淀粉样多肽激动剂
- 专利标题： Amylin agonist for treating depression, anxiety disorder and schizophrenia
- 专利标题（中）： 用于治疗抑郁症，焦虑障碍和精神分裂症的胰岛淀粉样多肽激动剂
-
申请号： US11910206申请日： 2006-03-31
-
公开(公告)号： US07671023B2公开(公告)日： 2010-03-02
- 发明人: Kevin D. Laugero , Michael R. Hanley , Christine M. Mack , David G. Parkes , Andrew A. Young
- 申请人： Kevin D. Laugero , Michael R. Hanley , Christine M. Mack , David G. Parkes , Andrew A. Young
- 申请人地址： US CA San Diego
- 专利权人： Amylin Pharmaceuticals, Inc.
- 当前专利权人： Amylin Pharmaceuticals, Inc.
- 当前专利权人地址： US CA San Diego
- 国际申请： PCT/US2006/012601 WO 20060331
- 国际公布： WO2006/105527 WO 20061005
- 主分类号： A61K38/00
- IPC分类号： A61K38/00 ; A01N37/18
摘要：
Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.